YDES
YD Bio Ltd
12.62
+0.22+1.77%
Dec 16, 4:00:00 PM EST

Upcoming Earnings 

Report date
≈ -/-

Earnings Call Transcripts

This Quarter (Q4 '25)

No earnings call transcript available yet

Last Quarter (Q3 '25)

No earnings call transcript available

Key Stats

Market Cap
889.98M
P/E (TTM)
-
Basic EPS (TTM)
-0.02
Dividend Yield
0%

About 

YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.

CEO
Dr. J. Douglas Ramsey Jr., Ph.D.
IPO
8/26/2025
Sector
Healthcare
Industry
Biotechnology